
SBC Medical Group Holdings Incorporated
SBCWWNASDAQIndustrialsSpecialty Business Services
Previous close
$0.335
+$0.0256 · +8.27%
SBCWW company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
66
Undervalued
Momentum
56
Neutral
Sentiment
67
Bullish
Risk resilience
54
Elevated Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteSBC Medical Group Holdings Incorporated (SBCWW) specializes in providing comprehensive management and support services to a network of aesthetic treatment centers. The company operates globally, with a significant presence in Japan, Vietnam, and the United States, alongside its other international activities. SBC's service portfolio for its franchisee clinics is extensive, covering everything from strategic advertising and marketing campaigns to human resources management, including staff recruitment and professional training programs. They also manage booking reservations for clients, assist with employee housing and facility rentals, and oversee the entire process of clinic construction and design. Furthermore, SBC facilitates the procurement of essential medical equipment and consumable supplies. In addition to these foundational services, SBC Medical Group offers advanced IT software solutions and a diverse range of cosmetic and reconstructive medical procedures. These treatments encompass common aesthetic enhancements such as breast augmentation, liposuction, and various rejuvenation therapies designed to address wrinkles, acne, scars, cellulite, excess fat, skin discoloration, and other visible signs of aging. Specialized services include laser skin toning and spot removal, double eyelid surgery, rhinoplasty (nose reshaping), and treatments for osmidrosis and hyperhidrosis. The company also provides hair transplants, gynecological formation treatments, laser hair removal, facial contouring surgeries, cosmetic dental procedures, and tattoo removal. Ophthalmic interventions like LASIK eye surgery and lateral canthoplasty are offered, alongside brow lifts, androgenetic alopecia (male pattern baldness) treatment, and methods for preventing cheek sagging. Established in 2000, the company maintains its corporate headquarters in Irvine, California.
- Industry
- Specialty Business Services
- Sector
- Industrials
- Headquarters
- US
- CEO
- Yoshiyuki Aikawa
- Listed since
- Aug 9, 2022
- Employees
- 863
Market position
Day range
Current $0.335
52-week range
Current $0.335
- Open
- $0.1749
- Previous close
- $0.3094
- Volume
- 2.33K
- 0.06× average
- Average volume
- 42.02K
- Average daily volume
- Market cap
- 34.45M USD
- Beta
- 0.59
- Market reference 1
- 50-day average
- $0.2316
- +44.68% above average
- 200-day average
- $0.227
- +47.60% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- -91.23M USD
- P/E (TTM)
- 0.71×
- P/B (TTM)
- 0.13×
- P/S (TTM)
- 0.2×
- EV / EBITDA
- -1.07×
- Earnings yield
- 243.85%
- Free cash flow yield
- 174.81%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 71.85%
- Operating margin
- 37.34%
- Net margin
- 27.99%
- Return on equity
- 20.54%
- Return on assets
- 13.40%
- Return on invested capital
- 12.61%
Financial health
- Debt / equity
- 0.18×
- Current ratio
- 3.78×
- Altman Z-score
- 2.64
- Piotroski F-score
- 6 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 173.61M USD | 205.42M USD | 193.54M USD | 174.16M USD |
| Cost of goods sold | 46.32M USD | 49.37M USD | 56.24M USD | 59.33M USD |
| Gross profit | 127.28M USD | 156.05M USD | 137.3M USD | 114.83M USD |
| Selling, general, and administrative | 59.8M USD | 70.69M USD | 66.24M USD | 93.48M USD |
| Operating expenses | 59.8M USD | 85.75M USD | 66.64M USD | 94.72M USD |
| Interest income | 198.32K USD | 19.94K USD | 86.75K USD | 472.38K USD |
| Interest expense | 160.58K USD | 28.3K USD | 45.29K USD | 31.44K USD |
| Depreciation and amortization | 2.68M USD | 3.8M USD | 12.25M USD | 5.93M USD |
| Operating income | 67.49M USD | 70.3M USD | 70.66M USD | 20.12M USD |
| Net income | 50.99M USD | 46.61M USD | 39.37M USD | 6.32M USD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 44%
- 4 beats, 5 misses, 0 met estimates
- Average EPS surprise
- -30.62%
- 9 comparable reports
- Latest EPS result
- 0.1
- Estimate 0.12 · Miss by 13.87%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
SBCWW peers
Continue in GoAI
Research SBCWWresearch.disclaimer





